StARD7 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the StARD7 protein, a member of the START (StAR-related lipid transfer) domain family. StARD7 plays a crucial role in intracellular lipid transport, particularly in the movement of phospholipids between cellular membranes. It is primarily involved in transferring phosphatidylcholine, an essential phospholipid component of cellular membranes, from the endoplasmic reticulum to the mitochondria. This lipid transfer is essential for maintaining mitochondrial membrane integrity and function, as phospholipids are crucial for the structural and functional properties of membranes. By facilitating lipid transport, StARD7 ensures that mitochondria have the necessary lipid components to support energy production, signaling, and other vital cellular processes. Inhibitors of StARD7 disrupt this lipid transport mechanism, potentially leading to imbalances in lipid distribution and altered membrane composition.
The mechanism of action of StARD7 inhibitors typically involves binding to the START domain of the protein, preventing it from interacting with phospholipid molecules or impairing its ability to facilitate their transfer between membranes. Some inhibitors may compete with lipid substrates for binding to the START domain, while others might induce conformational changes that reduce StARD7's lipid-binding affinity or transport capacity. By inhibiting StARD7, these compounds can lead to disruptions in mitochondrial lipid homeostasis, affecting mitochondrial structure, membrane fluidity, and overall cellular energy metabolism. Research into StARD7 inhibitors provides valuable insights into the role of lipid transfer proteins in cellular function and highlights the significance of phospholipid distribution in maintaining organelle integrity. Understanding how StARD7 regulates lipid trafficking between cellular compartments helps illuminate the broader importance of lipid metabolism in cellular homeostasis and membrane dynamics.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Miltefosine | 58066-85-6 | sc-203135 | 50 mg | $81.00 | 8 | |
Interferes with phospholipid metabolism and can disrupt mitochondrial membrane phospholipids. | ||||||
rac Perhexiline Maleate | 6724-53-4 | sc-460183 | 10 mg | $188.00 | ||
Modulates lipid metabolism and can affect mitochondrial function by altering lipid availability. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Influences phospholipid metabolism and can disrupt mitochondrial membranes. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Inhibits HMG-CoA reductase, potentially altering lipid biosynthesis and mitochondrial function. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Activates PPARα, which can lead to changes in lipid metabolism affecting mitochondrial lipids. | ||||||
(+)-Etomoxir sodium salt | 828934-41-4 | sc-215009 sc-215009A | 5 mg 25 mg | $151.00 $506.00 | 3 | |
Inhibits carnitine palmitoyltransferase-1, potentially influencing mitochondrial lipid uptake. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
May disrupt cellular signaling and lipid homeostasis, affecting mitochondrial function. | ||||||
Valinomycin | 2001-95-8 | sc-200991 | 25 mg | $250.00 | 3 | |
Forms ion channels in mitochondrial membranes, possibly disrupting membrane potential. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Inhibits ATP synthase, leading to altered mitochondrial energetics and lipid metabolism. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
Inhibits fatty acid synthase, possibly affecting lipid composition of mitochondria. | ||||||